News + Filings Transactions
|
STACK DAVID M
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/14/2023 | Pacira BioSciences, Inc. | PCRX | Grant | Common Stock | 32.7k | $0.00 | $0 | | 06/14/2023 |
| 06/14/2023 | Pacira BioSciences, Inc. | PCRX | Grant | Stock Option (Right to Buy) | 245.4k | $38.74 | $9.5M | | 06/14/2023 |
| 06/07/2023 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 5.3k | $37.87 | $201.7k | | 06/06/2023 |
| 06/06/2023 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 5.1k | $38.99 | $197.2k | | 06/06/2023 |
| 06/08/2022 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 7k | $59.10 | $416k | | 06/06/2022 |
| 06/08/2022 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 5k | $60.33 | $302k | | 06/06/2022 |
| 06/08/2022 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 1.3k | $61.31 | $78.6k | | 06/06/2022 |
| 06/08/2022 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 501 | $61.96 | $31k | | 06/06/2022 |
| 06/08/2022 | Pacira BioSciences, Inc. | PCRX | Grant | Common Stock | 21.5k | $0.00 | $0 | | 06/06/2022 |
| 06/08/2022 | Pacira BioSciences, Inc. | PCRX | Grant | Stock Option (Right to Buy) | 160.9k | $59.39 | $9.6M | | 06/06/2022 |
| 06/06/2022 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 12k | $61.37 | $734.3k | | 06/06/2022 |
| 04/28/2022 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 22.5k | $10.81 | $243.2k | | 04/28/2022 |
| 03/31/2022 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 22.5k | $10.81 | $243.2k | | 03/31/2022 |
| 01/25/2022 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 13.7k | $10.81 | $147.8k | | 01/25/2022 |
| 01/11/2022 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 15k | $10.81 | $162.2k | | 01/11/2022 |
| 11/16/2021 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 15k | $10.81 | $162.2k | | 11/16/2021 |
| 08/05/2021 | CHIASMA, INC | CHMA | Disposition | Stock Option (Right to Buy) | 13k | $7.98 | $103.7k | | 08/05/2021 |
| 08/05/2021 | CHIASMA, INC | CHMA | Disposition | Stock Option (Right to Buy) | 13k | $1.45 | $18.8k | | 08/05/2021 |
| 08/05/2021 | CHIASMA, INC | CHMA | Disposition | Stock Option (Right to Buy) | 13k | $1.35 | $17.6k | | 08/05/2021 |
| 08/05/2021 | CHIASMA, INC | CHMA | Disposition | Stock Option (Right to Buy) | 10k | $3.14 | $31.4k | | 08/05/2021 |
| 08/05/2021 | CHIASMA, INC | CHMA | Disposition | Stock Option (Right to Buy) | 72.7k | $5.57 | $404.8k | | 08/05/2021 |
| 08/05/2021 | CHIASMA, INC | CHMA | Disposition | Stock Option (Right to Buy) | 92k | $3.29 | $302.5k | | 08/05/2021 |
| 08/05/2021 | CHIASMA, INC | CHMA | Disposition | Common Stock | 25k | $0.00 | $0 | See Footnote | 08/05/2021 |
| 08/05/2021 | CHIASMA, INC | CHMA | Disposition | Stock Option (Right to Buy) | 13k | $5.81 | $75.5k | | 08/05/2021 |
| 06/14/2021 | AMARIN CORP PLC\UK | AMRN | Grant | Stock Option (Right to Buy) | 46k | $5.00 | $229.8k | | 06/14/2021 |
| 06/14/2021 | AMARIN CORP PLC\UK | AMRN | Grant | | 36k | $0.00 | $0 | | 06/14/2021 |
| 06/09/2021 | Pacira BioSciences, Inc. | PCRX | Grant | Common Stock | 17.8k | $0.00 | $0 | | 06/09/2021 |
| 06/09/2021 | Pacira BioSciences, Inc. | PCRX | Grant | Stock Option (Right to Buy) | 133.4k | $60.96 | $8.1M | | 06/09/2021 |
| 06/04/2021 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 14.9k | $61.04 | $909.8k | | 06/04/2021 |
| 06/04/2021 | AMARIN CORP PLC\UK | AMRN | Purchase | | 10k | $4.54 | $45.4k | See Footnote | 06/03/2021 |
| 06/03/2021 | AMARIN CORP PLC\UK | AMRN | Purchase | | 5k | $4.62 | $23.1k | See Footnote | 06/03/2021 |
| 05/12/2021 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 3k | $60.76 | $180.5k | | 03/24/2021 |
| 05/12/2021 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 14.7k | $62.08 | $910.7k | | 03/24/2021 |
| 05/12/2021 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 3.6k | $62.41 | $225.4k | | 03/24/2021 |
| 05/12/2021 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 21.2k | $10.81 | $229.7k | | 03/24/2021 |
|
|